
Jared Barsky
Examiner (ID: 12320)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1113 |
| Issued Applications | 490 |
| Pending Applications | 146 |
| Abandoned Applications | 501 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16655908
[patent_doc_number] => 20210052544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => METHODS OF TREATING AND/OR PREVENTING BEDSORES USING NABILONE
[patent_app_type] => utility
[patent_app_number] => 16/965483
[patent_app_country] => US
[patent_app_date] => 2019-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965483 | METHODS OF TREATING AND/OR PREVENTING BEDSORES USING NABILONE | Jan 20, 2019 | Abandoned |
Array
(
[id] => 14306129
[patent_doc_number] => 20190142768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => BUPROPION AS A MODULATOR OF DRUG ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/246347
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246347 | Bupropion as a modulator of drug activity | Jan 10, 2019 | Issued |
Array
(
[id] => 14435727
[patent_doc_number] => 20190175735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID
[patent_app_type] => utility
[patent_app_number] => 16/244880
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244880 | TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID | Jan 9, 2019 | Abandoned |
Array
(
[id] => 19521046
[patent_doc_number] => 12122753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione
[patent_app_type] => utility
[patent_app_number] => 16/961230
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13122
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961230 | Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione | Jan 9, 2019 | Issued |
Array
(
[id] => 16655907
[patent_doc_number] => 20210052543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Compositions and Methods for Treating Pain with Wogonin
[patent_app_type] => utility
[patent_app_number] => 16/961186
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961186 | Compositions and Methods for Treating Pain with Wogonin | Jan 8, 2019 | Abandoned |
Array
(
[id] => 14990857
[patent_doc_number] => 20190314386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/244020
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244020 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES | Jan 8, 2019 | Abandoned |
Array
(
[id] => 17306212
[patent_doc_number] => 11207294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
[patent_app_type] => utility
[patent_app_number] => 16/241469
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 13565
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241469 | Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 | Jan 6, 2019 | Issued |
Array
(
[id] => 14273417
[patent_doc_number] => 20190133993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => METHOD AND COMPOSITION FOR ACUTE TREATMENT OF SEIZURES
[patent_app_type] => utility
[patent_app_number] => 16/240617
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240617 | METHOD AND COMPOSITION FOR ACUTE TREATMENT OF SEIZURES | Jan 3, 2019 | Abandoned |
Array
(
[id] => 14099179
[patent_doc_number] => 20190091265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/213732
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213732
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/213732 | MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE | Dec 6, 2018 | Abandoned |
Array
(
[id] => 14662555
[patent_doc_number] => 10369154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Imipridones for gliomas
[patent_app_type] => utility
[patent_app_number] => 16/204964
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 45334
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204964 | Imipridones for gliomas | Nov 28, 2018 | Issued |
Array
(
[id] => 14072339
[patent_doc_number] => 20190085057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => MAST CELL STABILIZERS FOR TREATMENT OF HYPERCYTOKINEMIA AND VIRAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/192385
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/192385 | Mast cell stabilizers for treatment of hypercytokinemia and viral infection | Nov 14, 2018 | Issued |
Array
(
[id] => 14306185
[patent_doc_number] => 20190142796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => PHARMACEUTICAL COMBINATION COMPRISING LSZ102 AND RIBOCICLIB
[patent_app_type] => utility
[patent_app_number] => 16/190298
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190298
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/190298 | Pharmaceutical combination comprising LSZ102 and ribociclib | Nov 13, 2018 | Issued |
Array
(
[id] => 14342095
[patent_doc_number] => 20190153020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => Preparation and Uses of Obeticholic Acid
[patent_app_type] => utility
[patent_app_number] => 16/189559
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16189559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/189559 | Preparation and Uses of Obeticholic Acid | Nov 12, 2018 | Abandoned |
Array
(
[id] => 17922732
[patent_doc_number] => 11465965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Double-headed protease inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/760755
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96036
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760755 | Double-headed protease inhibitor | Nov 1, 2018 | Issued |
Array
(
[id] => 14501579
[patent_doc_number] => 20190194444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => GENE DELIVERY CARRIER
[patent_app_type] => utility
[patent_app_number] => 16/179698
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179698 | Gene delivery carrier | Nov 1, 2018 | Issued |
Array
(
[id] => 19179952
[patent_doc_number] => 11986527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Pharmaceutical formulations containing corticosteroids for topical administration
[patent_app_type] => utility
[patent_app_number] => 16/174023
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10549
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174023 | Pharmaceutical formulations containing corticosteroids for topical administration | Oct 28, 2018 | Issued |
Array
(
[id] => 13955483
[patent_doc_number] => 20190054085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 16/166101
[patent_app_country] => US
[patent_app_date] => 2018-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166101 | COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS | Oct 20, 2018 | Abandoned |
Array
(
[id] => 13955369
[patent_doc_number] => 20190054028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/165696
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165696 | Sustained-release formulations of colchicine and methods of using same | Oct 18, 2018 | Issued |
Array
(
[id] => 19731088
[patent_doc_number] => 12209079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => IDO/TDO inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/755953
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 52814
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755953 | IDO/TDO inhibitor | Oct 16, 2018 | Issued |
Array
(
[id] => 14682229
[patent_doc_number] => 20190240229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => GASTRIC AND COLONIC FORMULATIONS AND METHODS FOR MAKING AND USING THEM
[patent_app_type] => utility
[patent_app_number] => 16/149927
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/149927 | GASTRIC AND COLONIC FORMULATIONS AND METHODS FOR MAKING AND USING THEM | Oct 1, 2018 | Abandoned |